Erythrocyte-Mediated Drug Delivery for the Prevention of Stent Restenosis
NCT00484965
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Atherosclerosis
Acute-Phase Reaction
Interventions
PROCEDURE:
Coronary stenting
Sponsor
University of Rome Tor Vergata
Collaborators
[object Object]